Intracellular Ca²⁺ signalling and phenotype of vascular smooth muscle cells - PubMed (original) (raw)

Review

Intracellular Ca²⁺ signalling and phenotype of vascular smooth muscle cells

Vladimir V Matchkov et al. Basic Clin Pharmacol Toxicol. 2012 Jan.

Free article

Abstract

Vascular smooth muscle cells (VSMCs) express considerable plasticity in their phenotype and even can change their phenotype in vivo depending on the functional demand. In addition to contractile phenotype, VSMCs can be proliferative, migrating and/or synthetic. Importantly, contractile and non-contractile phenotypes differ significantly in their intracellular Ca²⁺ signalling, which is a consequence of difference in expression of Ca²⁺ transport proteins. Contractile VSMCs express Ca²⁺ transporters, including voltage-gated L-type Ca²⁺ channels and SERCA2a pump, which maintain low resting cytosolic Ca²⁺ and allow dynamic changes of Ca²⁺ in the spatial and temporal domain, while non-contractile VSMCs have significantly reduced voltage dependence of Ca²⁺ entry. These changes associated with phenotypic switch are consequences of changes in gene expression programmes, where the expression of phenotype-specific proteins and other proteins is suppressed. Importantly, Ca²⁺ -sensitive transcription factors, including serum response factor, cAMP response element-binding protein and nuclear factor of activated T lymphocytes, which are important for this phenotype switch, can be activated by different types of Ca²⁺ signalling. Thus, different Ca²⁺ transport proteins not only control averaged intracellular Ca²⁺ but also through their differences in the character of the Ca²⁺ signal modulate the activity of transcription factors and thus initiate phenotype switch. The essential stimuli for phenotype switch are unknown, but intracellular Ca²⁺ is an important second messenger in the cell transcription programme. This article reviews the relationship between intracellular Ca²⁺ signalling and VSMC phenotype.

PubMed Disclaimer

Cited by

Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway.
Huynh DTN, Jin Y, Van Nguyen D, Myung CS, Heo KS. Huynh DTN, et al. Antioxidants (Basel). 2022 Mar 27;11(4):643. doi: 10.3390/antiox11040643. Antioxidants (Basel). 2022. PMID: 35453328 Free PMC article.
Species-specific differences in the role of L-type Ca²⁺ channels in the regulation of coronary arterial smooth muscle contraction.
Yang H, Kuang SJ, Rao F, Xue YM, Liu XY, Shan ZX, Li XH, Zhu JN, Zhou ZL, Zhang XJ, Lin QX, Yu XY, Deng CY. Yang H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):151-7. doi: 10.1007/s00210-015-1173-7. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 26497185
Disparate biomechanical properties of the aorta in non-aneurysmal and aneurysmal mice treated with angiotensin II.
De Moudt S, Hendrickx JO, De Meyer GRY, Martinet W, Fransen P. De Moudt S, et al. Physiol Rep. 2022 Sep;10(18):e15410. doi: 10.14814/phy2.15410. Physiol Rep. 2022. PMID: 36117398 Free PMC article.
The Na,K-ATPase-Dependent Src Kinase Signaling Changes with Mesenteric Artery Diameter.
Zhang L, Aalkjaer C, Matchkov VV. Zhang L, et al. Int J Mol Sci. 2018 Aug 23;19(9):2489. doi: 10.3390/ijms19092489. Int J Mol Sci. 2018. PMID: 30142894 Free PMC article.
The bestrophin- and TMEM16A-associated Ca(2+)- activated Cl(–) channels in vascular smooth muscles.
Dam VS, Boedtkjer DM, Aalkjaer C, Matchkov V. Dam VS, et al. Channels (Austin). 2014;8(4):361-9. doi: 10.4161/chan.29531. Channels (Austin). 2014. PMID: 25478625 Free PMC article. Review.

Intracellular Ca²⁺ signalling and phenotype of vascular smooth muscle cells - PubMed (original) (raw)